SYNCRIP
Basic information
Region (hg38): 6:85607779-85644063
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SYNCRIP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 30 | 32 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 2 | 34 | 4 | 2 |
Variants in SYNCRIP
This is a list of pathogenic ClinVar variants found in the SYNCRIP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-85614764-A-G | SYNCRIP-related disorder | Uncertain significance (Apr 11, 2023) | ||
6-85614765-C-A | Inborn genetic diseases | Uncertain significance (Jan 31, 2024) | ||
6-85614779-T-A | Inborn genetic diseases | Uncertain significance (Mar 30, 2024) | ||
6-85614793-T-A | Inborn genetic diseases | Likely benign (May 24, 2023) | ||
6-85614805-G-C | Inborn genetic diseases | Uncertain significance (Dec 15, 2022) | ||
6-85614817-T-C | Inborn genetic diseases | Benign (Jun 07, 2022) | ||
6-85614820-T-G | Uncertain significance (Jul 22, 2024) | |||
6-85614826-G-C | Uncertain significance (Mar 17, 2023) | |||
6-85614840-T-C | SYNCRIP-related disorder | Likely benign (Sep 19, 2019) | ||
6-85614852-C-T | SYNCRIP-related disorder | Likely benign (Mar 28, 2019) | ||
6-85614876-G-C | Uncertain significance (Dec 29, 2023) | |||
6-85614886-T-C | Inborn genetic diseases | Uncertain significance (Feb 09, 2022) | ||
6-85614928-G-A | Inborn genetic diseases | Uncertain significance (Jun 17, 2024) | ||
6-85614946-A-C | SYNCRIP-related disorder | Uncertain significance (Jan 11, 2023) | ||
6-85614984-G-A | SYNCRIP-related disorder | Likely benign (Aug 14, 2019) | ||
6-85614986-G-A | Uncertain significance (Jul 25, 2022) | |||
6-85614988-C-A | Inborn genetic diseases | Uncertain significance (Aug 21, 2023) | ||
6-85615007-C-A | Inborn genetic diseases | Uncertain significance (Sep 30, 2024) | ||
6-85615025-C-T | Inborn genetic diseases | Uncertain significance (Nov 08, 2021) | ||
6-85615054-TG-AA | Autism spectrum disorder | association (-) | ||
6-85615058-A-C | Inborn genetic diseases | Uncertain significance (Mar 30, 2024) | ||
6-85615059-ATAACC-A | Uncertain significance (Dec 10, 2023) | |||
6-85615061-A-G | SYNCRIP-related disorder | Uncertain significance (Sep 28, 2024) | ||
6-85615064-C-T | Inborn genetic diseases | Uncertain significance (Sep 16, 2021) | ||
6-85615067-C-T | SYNCRIP-related Intellectual Disability | Uncertain significance (Jan 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SYNCRIP | protein_coding | protein_coding | ENST00000369622 | 10 | 35458 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000612 | 125739 | 0 | 6 | 125745 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.54 | 163 | 349 | 0.467 | 0.0000188 | 4066 |
Missense in Polyphen | 29 | 118.97 | 0.24375 | 1563 | ||
Synonymous | -0.886 | 128 | 116 | 1.10 | 0.00000620 | 1182 |
Loss of Function | 4.75 | 2 | 30.1 | 0.0663 | 0.00000158 | 389 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Heterogenous nuclear ribonucleoprotein (hnRNP) implicated in mRNA processing mechanisms. Component of the CRD- mediated complex that promotes MYC mRNA stability. Isoform 1, isoform 2 and isoform 3 are associated in vitro with pre-mRNA, splicing intermediates and mature mRNA protein complexes. Isoform 1 binds to apoB mRNA AU-rich sequences. Isoform 1 is part of the APOB mRNA editosome complex and may modulate the postranscriptional C to U RNA-editing of the APOB mRNA through either by binding to A1CF (APOBEC1 complementation factor), to APOBEC1 or to RNA itself. May be involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. Interacts in vitro preferentially with poly(A) and poly(U) RNA sequences. Isoform 3 may be involved in cytoplasmic vesicle-based mRNA transport through interaction with synaptotagmins. Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma- induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma activation assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation; seems not to be essential for GAIT complex function. {ECO:0000269|PubMed:11051545, ECO:0000269|PubMed:11134005, ECO:0000269|PubMed:11352648, ECO:0000269|PubMed:11574476, ECO:0000269|PubMed:19029303, ECO:0000269|PubMed:23071094}.;
Recessive Scores
- pRec
- 0.250
Intolerance Scores
- loftool
- rvis_EVS
- -0.56
- rvis_percentile_EVS
- 19.31
Haploinsufficiency Scores
- pHI
- 0.977
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.708
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Syncrip
- Phenotype
Gene ontology
- Biological process
- mRNA splicing, via spliceosome;osteoblast differentiation;RNA processing;RNA splicing;viral process;negative regulation of translation;CRD-mediated mRNA stabilization;cellular response to interferon-gamma
- Cellular component
- nucleus;nucleoplasm;endoplasmic reticulum;membrane;CRD-mediated mRNA stability complex;catalytic step 2 spliceosome;histone pre-mRNA 3'end processing complex;GAIT complex;ribonucleoprotein complex
- Molecular function
- RNA binding;mRNA binding;protein binding;poly(A) binding;mRNA 5'-UTR binding